Compare eBay Inc (EBAY) vs Globus Medical Inc. Class A Common Stock (GMED) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
eBay Inc vs Globus Medical Inc. Class A Common Stock — how do they compare? eBay Inc trades at $119.53 (market cap $52.01B), while Globus Medical Inc. Class A Common Stock trades at $76.99 (market cap $10.25B). The key difference: eBay Inc is far larger — about 5.1× Globus Medical Inc. Class A Common Stock's market cap, and eBay Inc pays a 1.06% dividend while Globus Medical Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold eBay Inc for 134 Days and Globus Medical Inc. Class A Common Stock for 0 Days on average.
| EBAY | GMED | |
|---|---|---|
Market Cap | $52.01B | $10.25B |
Volume | 3,194,736 | 1,059,528 |
Sector | Consumer Cyclical | Health |
52-Week High | $118.96 | $96.82 |
52-Week Low | $79.41 | $58.33 |
Typical Hold Time | 134 Days | 0 Days |
Enterprise Value | $55.83B | $9.76B |
Dividend Yield | 1.06% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EBAY trades at $116.41, up 1.54% today, near its consensus price target of $117.89. The stock shows bullish technical momentum with consistent earnings beats in recent quarters. Fundamentally, EBAY maintains strong profitability with 72.05% gross margins and 18.57% net income margins, though revenue growth remains modest. Recent news highlights strategic focus on collectibles and live commerce while facing competitive pressures from Amazon's new multi-platform tools.
EBAY presents a balanced investment case with solid profitability and analyst support (49% buy ratings) but faces execution risks in a competitive e-commerce landscape. The current valuation at 24.55 P/E appears reasonable given earnings growth potential, though investor sentiment is tempered by insider selling and mixed technical indicators suggesting potential near-term consolidation.
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About eBay Inc
eBay Inc. is a global commerce company. The Company's platforms are designed to enable sellers worldwide to organize and offer their inventory for sale and buyers to find and buy it. eBay's items can be new or used, plain or luxurious, commonplace or rare, trendy or one-of-a-kind.
Read more on EBAY →About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →
